Management of lung cancer-Reference-Cited by-同舟云学术

Management of lung cancer

Published:2020-04 Issue:4 Volume:48 Page:273-278
ISSN:1357-3039
Container-title:Medicine
language:en
Short-container-title:Medicine

Author:

Coakley Maria,Popat Sanjay

Funder

Royal Marsden Hospital

NIHR Biomedical Research Centre

Publisher

Elsevier BV

Subject

General Medicine

Reference5 articles.

1. Cancer Research UK. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer/incidence (accessed 09 December 2019).

2. Reduced lung-cancer mortality with low-dose computed tomographic screening;Aberle;N Engl J Med,2011

3. Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer;Kerr;Ann Oncol,2014

4. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial

5. Early palliative care for patients with metastatic non-small-cell lung cancer;Temel;N Engl J Med,2010

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of Some New Coumarin-thiazolidine-2,4-dione-1,2,3-triazole Hybrids as Tubulin Targeting Anti-Lung Cancer Agents;Russian Journal of Bioorganic Chemistry;2024-04

2. Artemisinin‐isatin hybrids tethered via ethylene linker and their anti‐lung cancer activity;Archiv der Pharmazie;2022-12-26

3. The anti-lung cancer activity of propylene tethered dihydroartemisinin-isatin hybrids;Arabian Journal of Chemistry;2022-04

4. Three-Carbon Linked Dihydroartemisinin-Isatin Hybrids: Design, Synthesis and Their Antiproliferative Anticancer Activity;Frontiers in Pharmacology;2022-01-26

5. Design, Synthesis and Anti-Lung Cancer Evaluation of 1, 2, 3-Triazole Tethered Dihydroartemisinin-Isatin Hybrids;Frontiers in Pharmacology;2021-12-16